Advanced Search

Novel Products Stocks List

Symbol Grade Name % Change
DVAX D Dynavax Technologies Corporation -13.01
EARS D Auris Medical Holding AG -7.69
QLGN F Qualigen Therapeutics, Inc. -7.46
APLT D Applied Therapeutics, Inc. -2.95
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Biopharmaceutical Asthma Auditory System Autoimmune And Inflammatory Disease Autoimmune And Inflammatory Diseases Biotechnology B Vaccine Cancer Cardiomyopathy Cardiovascular Disease Chemical Chronic Obstructive Pulmonary Disease Clinics Diabetes Diabetes Mellitus Diabetic Peripheral Neuropathy Diabetic Retinopathy Diseases Drug Delivery Drug Delivery Devices

Related ETFs - A few ETFs which own one or more of the above listed Novel Products stocks.

Symbol Grade Name Weight
BBC C Virtus LifeSci Biotech Clinical Trials ETF 1.23
GERM C ETFMG Treatments Testing and Advancements ETF 0.79
XBI D SPDR Series Trust SPDR S&P Biotech ETF 0.61
LABD F Direxion Daily S&P Biotech Bear 3X Shares 0.24
IWC B iShares Microcap ETF 0.21
View all Novel Products related ETFs...
Compare ETFs
  • Compare BBC to GERM
  • Compare GERM to LABD
  • Compare XBI to IWC

    • Recent Signals

    Date Stock Signal Type
    2021-02-25 APLT 20 DMA Resistance Bearish
    2021-02-25 APLT MACD Bearish Centerline Cross Bearish
    2021-02-25 APLT 50 DMA Support Bullish
    2021-02-25 DVAX Fell Below 20 DMA Bearish
    2021-02-25 EARS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-25 EARS 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-02-25 EARS Stochastic Reached Oversold Weakness
    2021-02-25 EARS Fell Below 20 DMA Bearish

    Recent News for Novel Products Stocks

    Date Stock Title
    Feb 24 DVAX Earnings Preview for Dynavax Technologies
    Feb 23 APLT Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
    Feb 22 APLT Applied Therapeutics, Inc. Announces Closing of Public Offering
    Feb 21 DVAX Dynavax’s Hepatitis B Vaccine Authorized In Europe; Shares Rise 6%
    Feb 20 DVAX The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
    Feb 19 DVAX Why Dynavax Stock Jumped Today
    Feb 19 DVAX Dynavax wins European approval for Hep B vaccine
    Feb 19 DVAX Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Asthma Auditory System Autoimmune And Inflammatory Disease Autoimmune And Inflammatory Diseases Biotechnology B Vaccine Cancer Cardiomyopathy Cardiovascular Disease Chemical Chronic Obstructive Pulmonary Disease Clinics Diabetes Diabetes Mellitus Diabetic Peripheral Neuropathy Diabetic Retinopathy Diseases Drug Delivery Drug Delivery Devices

    Browse All Tags